Blog Articles, tagged with: Ocrelizumab

Ocrelizumab

Thumbnail

Minister for Health Simon Harris has agreed to meet with MS Ireland regarding ocrelizumab MS Ireland welcomed the news this morning (Wednesday, 28th March 2018) that a spokesperson from the office of Simon Harris has agreed that the Minister will meet with representatives from the organisation &...

Published by MS Ireland on Wednesday March 28 2018 10:20 AM

View Article

Ocrelizumab

Thumbnail

MS Ireland has made a Patient Group Submission to the National Centre for Pharmaco-economics regarding Ocrevus (ocrelizumab)  Ocrelizumab is first and only approved disease-modifying medicine for people with early primary progressive MS. The medication is currently being assessed by the NCP...

Published by MS Ireland on Thursday February 22 2018 08:43 AM

View Article

Ocrelizumab Receives Licence in EU

Thumbnail

Roche’s ocrelizumab receives licence in the EU for relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) Ocrelizumab is first and only approved disease-modifying medicine for people in EU with early PPMS Dublin, 12 January 2018: Roche announced toda...

Published by Roche on Monday January 15 2018 12:13 PM

View Article

Ocrelizumab

Thumbnail

Ocrelizumab recommended for licencing by European Medicines Agency for relapsing remitting and early primary progressive MS The European Medicines Agency recommends licensing for ocrelizumab (Ocrevus) for treating relapsing and primary progressive MS. The European Medicines Agency (EMA) has rec...

Published by MS Ireland on Monday November 13 2017 10:02 AM

View Article

Hope

Thumbnail

‘This week Helen Farrell examines how the years of living with MS have made an impact on her hopes for the future’ This week a brand new MS medication, Ocrevus (ocrelizumab), was approved by the Federal Drugs Authority (FDA)in the United States for both primary progressive (PPMS) and...

Published by Helen Farrell on Thursday April 06 2017 11:00 AM

View Article

Ocrelizumab

Thumbnail

First treatment licensed for primary progressive MS in the US Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US. It is the first licensed treatment for people with primary progressive MS. The decision was made by the US Food and Drug Administrat...

Published by MS Ireland on Thursday March 30 2017 03:09 PM

View Article

Clinical Trial Recruiting

Thumbnail

**NO LONGER RECRUITING** A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)  A clinical trial for potential new therapy Ocrelizumab is recruiting in Irish centres. Ocrelizumab has been found to have potential benefits for both relapsing remitting MS a...

Published by MS Ireland on Wednesday February 15 2017 10:14 AM

View Article

Ocrelizumab

Thumbnail

Ocrelizumab is a new medication which has recently been shown in three, large phase-three clinical trials to have beneficial effects in both relapsing-remitting and primary progressive MS. When available, Ocrelizumab will be a welcome addition to the number of drugs currently licensed for relapsi...

Published by MS Ireland on Tuesday January 03 2017 10:28 AM

View Article


Latest News

More news

What's hot

Whats_hot

Christmas Shop is Open!

Christmas cards, calendar and stocking fillers... start ticking off your Christmas list now!! 

Find out more

Events Calendar

» Our next Event

22 November 2018: Yoga classes to help improve health and wellbeing. Ongoing throughout 2018

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow